Find similar content

Source channel @githubtrending · Post #14827 · Jun 12

#typescript#desktop#docx#electron#html#languages#libreoffice#linux#macos#markdown#nodejs#office#offline#pandoc#pdf#productivity#windows#zettlr Zettlr is a free, open-source app that helps you write, organize, and publish your notes and documents using simple Markdown files. It works on Windows, macOS, and Linux, and lets you manage your notes with features like workspaces, tags, and powerful search, so you can quickly find what you need. Zettlr supports easy citations with reference managers like Zotero, offers code highlighting, dark mode, and flexible export options to PDF, Word, or LaTeX, making it ideal for students, researchers, and writers who want a privacy-focused, distraction-free way to work with their ideas and publish their work[1][3][5]. The benefit is that you can focus on your content, not formatting, and easily turn your notes into professional documents. https://github.com/Zettlr/Zettlr

Hashtags

#typescript #desktop #docx #electron #html #languages #libreoffice #linux #macos #markdown #nodejs #office #offline #pandoc #pdf #productivity #windows #zettlr

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment